Asia Pacific Nerve Repair and Regeneration Market Size, 2028

Asia Pacific Nerve Repair and Regeneration Market Size, Share & Industry Trends Analysis Report By Surgery, By Product (Neuromodulation Surgery Devices and Biomaterials), By Country and Growth Forecast, 2022 - 2028

Published Date: May-2022 | Number of Pages: 82 | Format: PDF | Report ID: KBV-18336

Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support


Get in-depth analysis of the COVID-19 impact on the Asia Pacific Nerve Repair and Regeneration Market

Market Report Description

The Asia Pacific Nerve Repair and Regeneration Market would witness market growth of 7.1% CAGR during the forecast period (2022-2028).

Stem cell treatment for nerve injury has a lot of potential, and it has a lot of advantages over other, more conventional therapies like surgery. It has been shown in studies to lessen overall peripheral nerve damage while also promoting tissue regeneration. This therapy may restore total functional recovery in some cases, but not all. Damage to the neurological system can be caused by a variety of factors. Diabetic patients may develop numbness as a result of neuropathy caused by long-term elevated blood sugar levels. Chemotherapy with some types of drugs can be hazardous to healthy nerve tissue. Herpes zoster is one of several viral diseases that can cause nerve damage. Finally, nerve injury is common in automobile accidents and other types of trauma.

These advancements are being achieved in peripheral nerve surgery, and a new surgical discipline including peripheral neurosurgery reconstruction is emerging. Neurosurgery, orthopaedics, hand and plastic surgery, and neurology, spinal injuries, neurophysiology, and rehabilitation medicine are just a few of the surgical disciplines involved in peripheral nerve surgery. Nerve decompression, graft reconstruction, microsurgical repair, neurolysis, and nerve transfer operations may be necessary by surgeons. When paralysis is long-term or not responsive to a main nerve treatment, tendon transfer, arthrodesis, and functioning free muscle transfers is used.

Alzheimer's disease and other kinds of dementia are becoming more common among the elderly in emerging countries, where the population is rapidly ageing. By 2020, it is anticipated that 70 percent of the world's population aged 60 and up would be residing in emerging economies, with India accounting for 14.2 percent. Only prospective incidence studies can provide accurate estimates of the rate about which new disease develops. Incidence rates of Alzheimer's disease have been found to be lower in Asian nations than in the industrialized world. Despite the availability of dementia prevalence research from Asian nations such as India, there is a scarcity of incidence data, especially from selective long-term studies.

As part of the cognitive in older adults in Trivandrum (COAT) project, researchers previously reported that the age-adjusted prevalence of dementia, including Alzheimer's disease, was 4.86 percent in a community living population in the southern Indian province of Kerala. The incidence rates of the COAT cohort after a ten-year follow-up are reported in this study. With the rising cases of these diseases and increasing R&D activities for improving nerve repair and regeneration solutions, the demand and growth of regional market would witness a spur in the coming years.

The China market dominated the Asia Pacific Nerve Repair and Regeneration Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $632.2 Million by 2028. The Japan market is anticipated to grow at a CAGR of 6.4% during (2022 - 2028). Additionally, The India market would showcase a CAGR of 7.7% during (2022 - 2028).

Based on Surgery, the market is segmented into Neuromodulation Surgery, Direct Neuropathy, Nerve Grafting, and Stem Cell Therapy. Based on Product, the market is segmented into Neuromodulation Surgery Devices and Biomaterials. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

Free Valuable Insights: The Worldwide Nerve Repair and Regeneration Market is Projected to reach USD 9.4 Billion by 2028, at a CAGR of 6.4%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Boston Scientific Corporation, Integra Lifesciences Corporation, Medtronic PLC, Axogen, Inc., Stryker Corporation, Checkpoint Surgical, Inc., Polyganics BV, Synovis Micro Companies Alliance, Inc. (Baxter International, Inc.), and OrthoMed, Inc.

Scope of the Study

Market Segments Covered in the Report:

By Surgery

  • Neuromodulation Surgery
  • Direct Neuropathy
  • Nerve Grafting
  • Stem Cell Therapy

By Product

  • Neuromodulation Surgery Devices
  • Biomaterials

By Country

  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

Key Market Players

List of Companies Profiled in the Report:

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Integra Lifesciences Corporation
  • Medtronic PLC
  • Axogen, Inc.
  • Stryker Corporation
  • Checkpoint Surgical, Inc.
  • Polyganics BV
  • Synovis Micro Companies Alliance, Inc. (Baxter International, Inc.)
  • OrthoMed, Inc.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • The highest number of market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Related Reports:

Global Nerve Repair and Regeneration Market Report 2022-2028

North America Nerve Repair and Regeneration Market Report 2022-2028

Europe Nerve Repair and Regeneration Market Report 2022-2028

LAMEA Nerve Repair and Regeneration Market Report 2022-2028

Purchase Report


Special Pricing & Discounts

  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities